Document is current
Any future updates will be listed below
-
Authors
Gerber, Felix https://orcid.org/0000-0002-9736-1907
Gupta, Ravi
Lejone, Thabo Ishmael
Tahirsylaj, Thesar
Lee, Tristan
Kohler, Maurus
Haldemann, Maria Ines
Räber, Fabian
Chitja, Mamakhala
Manthabiseng, Molulela
Khomolishoele, Makhebe
Mota, Mota
Bane, Matumaole
Sematle, Pauline Mamorontsane
Makabateng, Retselisitsoe
Mphunyane, Madavida
Phaaroe, Sejojo
Basler, Dave
Kindler, Kevin
Seelig, Eleonora
Briel, Matthias
Chammartin, Frédérique
Labhardt, Niklaus Daniel
Amstutz, Alain
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (323530_207035)
Direktion für Entwicklung und Zusammenarbeit (7F-10345.01.01)
World Diabetes Foundation (WDF20-1778)
University of Basel
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 12 October 2023
First Online: 24 October 2023
Declarations
:
: The TwiC was approved by the National Health Research and Ethics Committee (NH-REC) of Lesotho (ID 102–2022) and the Ethikkomission Nordwest- und Zentralschweiz (EKNZ) in Switzerland (ID AO_2022_00077). Protocol amendments will be communicated to the involved ethics committees and updated on ClinicalTrials.gov.Participants for this TwiC are recruited among the ComBaCaL cohort population. All participants gave written informed consent with electronic signatures to participate in the ComBaCaL cohort study and to be randomly selected for nested TwiCs (26, 27).
: Not applicable.
: The authors declare that they have no competing interests.
